0001127602-18-011394.txt : 20180313
0001127602-18-011394.hdr.sgml : 20180313
20180313164322
ACCESSION NUMBER: 0001127602-18-011394
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180313
FILED AS OF DATE: 20180313
DATE AS OF CHANGE: 20180313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Herendeen Paul
CENTRAL INDEX KEY: 0001374175
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 18687024
MAIL ADDRESS:
STREET 1: C/O ZOETIS INC.
STREET 2: 100 CAMPUS DRIVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-03-13
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001374175
Herendeen Paul
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
EVP and CFO
Common Stock, No Par Value
2018-03-13
4
P
0
15000
16.098
A
231492
D
The price in Column 4 is a weighted average price. The prices actually paid in this transaction range from $16.09 to $16.10 per Common Share.
The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range reported above.
/s/ Kirsten O'Donnell, attorney-in-fact for Paul Herendeen
2018-03-13